Health care stakeholders struggling to comply with the HIPAA 5010 transaction sets need not worry about one thing-- the next-generation 6020 transactions are not coming to a theater near you any time soon.
The 6020 transactions are being developed and are undergoing a public comment period that closes on March 7, 2012. But Accredited Standards Committee X12, developer of the HIPAA transactions, will not soon recommend adoption of technical reports, called TR3s, which would be a major step toward adoption of 6020.
The committee recognizes that the industry is not ready to begin another implementation cycle at this time, says ASC X12 chair Cathy Sheppard. However, public comments on the 6020 technical reports still are important in shaping the next version of HIPAA transactions to meet business needs.
More information is available athttp://forums.x12.org.
Source: Health Data Management
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More